102 related articles for article (PubMed ID: 24773489)
1. Mechanistically-based QSARs to describe metabolic constants in mammals.
Pirovano A; Huijbregts MA; Ragas AM; Veltman K; Hendriks AJ
Altern Lab Anim; 2014 Mar; 42(1):59-69. PubMed ID: 24773489
[TBL] [Abstract][Full Text] [Related]
2. The utilisation of structural descriptors to predict metabolic constants of xenobiotics in mammals.
Pirovano A; Brandmaier S; Huijbregts MA; Ragas AM; Veltman K; Hendriks AJ
Environ Toxicol Pharmacol; 2015 Jan; 39(1):247-58. PubMed ID: 25531263
[TBL] [Abstract][Full Text] [Related]
3. Compound lipophilicity as a descriptor to predict binding affinity (1/K(m)) in mammals.
Pirovano A; Huijbregts MA; Ragas AM; Hendriks AJ
Environ Sci Technol; 2012 May; 46(9):5168-74. PubMed ID: 22497447
[TBL] [Abstract][Full Text] [Related]
4. A comparison of octanol-water partitioning between organic chemicals and their metabolites in mammals.
Pirovano A; Borile N; Jan Hendriks A
Chemosphere; 2012 Aug; 88(8):1036-41. PubMed ID: 22475150
[TBL] [Abstract][Full Text] [Related]
5. Activities of xenobiotic metabolizing enzymes in rat placenta and liver in vitro.
Fabian E; Wang X; Engel F; Li H; Landsiedel R; van Ravenzwaay B
Toxicol In Vitro; 2016 Jun; 33():174-9. PubMed ID: 26944803
[TBL] [Abstract][Full Text] [Related]
6. [Research advances in non-P450-mediated drug oxidative metabolism].
Zhou L; Zhong DF; Chen XY
Yao Xue Xue Bao; 2017 Jan; 52(1):8-18. PubMed ID: 29911369
[TBL] [Abstract][Full Text] [Related]
7. Some distinctions between flavin-containing and cytochrome P450 monooxygenases.
Cashman JR
Biochem Biophys Res Commun; 2005 Dec; 338(1):599-604. PubMed ID: 16112078
[TBL] [Abstract][Full Text] [Related]
8. Quantitative structure-activity relationships (QSARs) for inhibitors and substrates of CYP2B enzymes: importance of compound lipophilicity in explanation of potency differences.
Lewis DF; Ito Y; Lake BG
J Enzyme Inhib Med Chem; 2010 Oct; 25(5):679-84. PubMed ID: 20100069
[TBL] [Abstract][Full Text] [Related]
9. Cytochromes P450: a structure-based summary of biotransformations using representative substrates.
Brown CM; Reisfeld B; Mayeno AN
Drug Metab Rev; 2008; 40(1):1-100. PubMed ID: 18259985
[TBL] [Abstract][Full Text] [Related]
10. Going Beyond Common Drug Metabolizing Enzymes: Case Studies of Biotransformation Involving Aldehyde Oxidase, γ-Glutamyl Transpeptidase, Cathepsin B, Flavin-Containing Monooxygenase, and ADP-Ribosyltransferase.
Fan PW; Zhang D; Halladay JS; Driscoll JP; Khojasteh SC
Drug Metab Dispos; 2016 Aug; 44(8):1253-61. PubMed ID: 27117704
[TBL] [Abstract][Full Text] [Related]
11. Distinct but parallel evolutionary patterns between alcohol and aldehyde dehydrogenases: addition of fish/human betaine aldehyde dehydrogenase divergence.
Hjelmqvist L; Norin A; El-Ahmad M; Griffiths W; Jörnvall H
Cell Mol Life Sci; 2003 Sep; 60(9):2009-16. PubMed ID: 14523561
[TBL] [Abstract][Full Text] [Related]
12. Measurements of flavin-containing monooxygenase (FMO) activities.
Rose RL
Curr Protoc Toxicol; 2002 Nov; Chapter 4():Unit4.9. PubMed ID: 20945301
[TBL] [Abstract][Full Text] [Related]
13. QSARs for estimating intrinsic hepatic clearance of organic chemicals in humans.
Pirovano A; Brandmaier S; Huijbregts MA; Ragas AM; Veltman K; Hendriks AJ
Environ Toxicol Pharmacol; 2016 Mar; 42():190-7. PubMed ID: 26874337
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and specificity of human liver aldehyde dehydrogenases toward aliphatic, aromatic, and fused polycyclic aldehydes.
Klyosov AA
Biochemistry; 1996 Apr; 35(14):4457-67. PubMed ID: 8605195
[TBL] [Abstract][Full Text] [Related]
15. NADPH-dependent, regioselective S-oxidation of a thionosulfur- and thioether-containing xenobiotic, diethyldithiocarbamate methyl ester by rat liver microsomes.
Madan A; Faiman MD
Drug Metab Dispos; 1994; 22(2):324-30. PubMed ID: 8013289
[TBL] [Abstract][Full Text] [Related]
16. Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics.
Philpot RM; Smith BR
Environ Health Perspect; 1984 Apr; 55():359-67. PubMed ID: 6376107
[TBL] [Abstract][Full Text] [Related]
17. A method for the characterization of aldehyde dehydrogenase with use of alcohol dehydrogenase.
Herold DA; Keil K; Bruns DE
Res Commun Chem Pathol Pharmacol; 1987 Nov; 58(2):257-67. PubMed ID: 3423423
[TBL] [Abstract][Full Text] [Related]
18. [Cloning, expression and characterization of alcohol dehydrogenase and aldehyde dehydrogenase from Bacillus pseudofirmus OF4].
Ju J; Ma N; Zhao R; Liu J; Xu S; Zhao B
Wei Sheng Wu Xue Bao; 2013 Apr; 53(4):363-71. PubMed ID: 23858711
[TBL] [Abstract][Full Text] [Related]
19. Quantitative structure-activity relationships (QSARs) in inhibitors of various cytochromes P450: the importance of compound lipophilicity.
Lewis DF; Lake BG; Dickins M
J Enzyme Inhib Med Chem; 2007 Feb; 22(1):1-6. PubMed ID: 17373540
[TBL] [Abstract][Full Text] [Related]
20. P450 structures and oxidative metabolism of xenobiotics.
Lewis DF
Pharmacogenomics; 2003 Jul; 4(4):387-95. PubMed ID: 12831319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
